tm logo
QUANTIPLEX
Live/Registered
SECTION 71 ACCEPTED

on 01 Jun 2024

Last Applicant/ Owned by

Qiagen Str. 1

Hilden

DE

40724

Serial Number

79124568 filed on 12th Dec 2012

Registration Number

4405272 registered on 24th Sep 2013

in the Principal Register

Correspondent Address

Victoria Friedman

Victoria Friedman Dennemeyer & Associates, LLC

Suite 2100

CHICAGO, IL 60606

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

QUANTIPLEX

Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, [ diagnostic preparations except for human or veterinary medical purposes, namely, nonmedical ] reagents, enzymes and buffer solutions for [ scientific and medical research use for sample preparation, modification and manipulation of cells and for conducting marking, separating, isolating, purifying Read More

Classification Information


Class [005]
Pharmaceutical Products


[ Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, namely, diagnostic preparations for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, namely, reagents, enzymes and buffer solutions for nucleic acid amplification by polymerase chain reaction (PCR); chemical, biochemical and biotechnological preparations, namely, reagents, enzymes and buffer solutions for sample preparation, modification and manipulation of cells and for conducting marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances for diagnostic medical and clinical use, namely, reagents, enzymes and buffer solutions for nucleic acid amplification by polymerase chain reaction (PCR); ] kits containing [ preparations for medical and veterinary diagnostic purposes, in particular for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids from biological or ] biochemical sample material for nucleic acid amplification by polymerase chain reaction (PCR)


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products


Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, [ diagnostic preparations except for human or veterinary medical purposes, namely, nonmedical ] reagents, enzymes and buffer solutions for [ scientific and medical research use for sample preparation, modification and manipulation of cells and for conducting marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, namely, reagents, enzymes and buffer solutions for ] nucleic acid amplification by polymerase chain reaction (PCR) [ ; kits comprising chemicals for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, namely, nucleic acids of biological or biochemical sample material comprising chemicals for reagents, enzymes and buffer solutions for nucleic acid amplification by polymerase chain reaction (PCR) ]


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79124568

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 10169822TR

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
01st Jun 2024NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
01st Jun 2024REGISTERED-SEC.71 ACCEPTED
28th May 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
13th May 2024POST REGISTRATION ACTION MAILED - SEC.71
05th May 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05th Sep 2023TEAS SECTION 71 RECEIVED
30th Dec 2022INTERNATIONAL REGISTRATION RENEWED
24th Sep 2022COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
27th Aug 2019NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
27th Aug 2019REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.